603313 Stock Overview
Research, develops, produces, and sells memory foam mattresses, pillows, sofas, and other household products in China. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Healthcare Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥6.75 |
52 Week High | CN¥11.61 |
52 Week Low | CN¥5.26 |
Beta | 1.2 |
11 Month Change | 1.66% |
3 Month Change | 14.21% |
1 Year Change | -35.41% |
33 Year Change | -62.83% |
5 Year Change | -51.73% |
Change since IPO | -48.59% |
Recent News & Updates
Market Participants Recognise Healthcare Co.,Ltd.'s (SHSE:603313) Earnings
Sep 26HealthcareLtd's (SHSE:603313) Profits Appear To Have Quality Issues
Sep 06Shareholder Returns
603313 | CN Consumer Durables | CN Market | |
---|---|---|---|
7D | -4.0% | -1.9% | -2.1% |
1Y | -35.4% | 16.1% | 2.8% |
Return vs Industry: 603313 underperformed the CN Consumer Durables industry which returned 16.1% over the past year.
Return vs Market: 603313 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
603313 volatility | |
---|---|
603313 Average Weekly Movement | 7.3% |
Consumer Durables Industry Average Movement | 7.9% |
Market Average Movement | 8.4% |
10% most volatile stocks in CN Market | 12.7% |
10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 603313 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603313's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2003 | 7,443 | Zhang Gen Ni | www.hkfoam.com |
Healthcare Co.,Ltd. research, develops, produces, and sells memory foam mattresses, pillows, sofas, and other household products in China. It offers adjustable bases, mattress protectors, and electric beds, as well as kids product.
Healthcare Co.,Ltd. Fundamentals Summary
603313 fundamental statistics | |
---|---|
Market cap | CN¥3.85b |
Earnings (TTM) | -CN¥159.31m |
Revenue (TTM) | CN¥8.39b |
0.5x
P/S Ratio-24.2x
P/E RatioIs 603313 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
603313 income statement (TTM) | |
---|---|
Revenue | CN¥8.39b |
Cost of Revenue | CN¥5.17b |
Gross Profit | CN¥3.22b |
Other Expenses | CN¥3.38b |
Earnings | -CN¥159.31m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.28 |
Gross Margin | 38.41% |
Net Profit Margin | -1.90% |
Debt/Equity Ratio | 66.2% |
How did 603313 perform over the long term?
See historical performance and comparison